Safety and tolerability of recombinant modified vaccinia virus Ankara expressing an HIV-1 gag/multiepitope immunogen (MVA.HIVA) in HIV-1-infected persons receiving combination anti... by Dorrell, L, Williams, P, Suttill, A, Brown, D, Roberts, J, Conlon, C, Hanke, T, McMichael, A

Impaired IFN-gamma-secreting capacity in mycobacterial antigen-specific CD4 T cells during chronic HIV-1 infection despite long-term HAART. by Sutherland, R, Yang, H, Scriba, T, Ondondo, B, Robinson, N, Conlon, C, Suttill, A, Mcshane, H, Fidler, S, McMichael, A, Dorrell, L

Therapeutic immunization of highly active antiretroviral therapy-treated HIV-1-infected patients: safety and immunogenicity of an HIV-1 gag/poly-epitope DNA vaccine. by Dorrell, L, Yang, H, Iversen, A, Conlon, C, Suttill, A, Lancaster, M, Dong, T, Cebere, I, Edwards, A, Rowland-Jones, S, Hanke, T, Mcmichael, A

Immunisation with recombinant modified vaccinia virus Ankara expressing HIV-1 gag in HIV-1-infected subjects stimulates broad functional CD4+ T cell responses. by Ondondo, B, Yang, H, Dong, T, di Gleria, K, Suttill, A, Conlon, C, Brown, D, Williams, P, Rowland-Jones, S, Hanke, T, Mcmichael, A, Dorrell, L

Detection of broad functional gag-specific CD4+T cell responses in HIV-1-infected subjects following therapeutic immunization with rMVA expressing an HIV-1 gag immunogen by Ondondo, B, Yang, H, Dong, T, de Gleria, K, Suttill, A, Conlon, C, Brown, D, Williams, P, Bowness, P, Rowland-Jones, S, Hanke, T, McMichael, A, Dorrell, L

Expansion and diversification of virus-specific T cells following immunization of human immunodeficiency virus type 1 (HIV-1)-infected individuals with a recombinant modified vacci... by Dorrell, L, Yang, H, Ondondo, B, Dong, T, di Gleria, K, Suttill, A, Conlon, C, Brown, D, Williams, P, Bowness, P, Goonetilleke, N, Rostron, T, Rowland-Jones, S, Hanke, T, McMichael, A